STOCK TITAN

[SCHEDULE 13G/A] Myriad Genetics Inc SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:07/29/2025
Myriad Genetics

NASDAQ:MYGN

MYGN Rankings

MYGN Latest News

MYGN Latest SEC Filings

MYGN Stock Data

475.39M
90.22M
2.9%
98.4%
9.66%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
SALT LAKE CITY